Passumpsic Savings Bank Cuts Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Passumpsic Savings Bank lessened its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 1.7% in the 4th quarter, Holdings Channel.com reports. The fund owned 10,073 shares of the biotechnology company’s stock after selling 176 shares during the period. Axon Enterprise comprises 3.7% of Passumpsic Savings Bank’s investment portfolio, making the stock its 2nd largest holding. Passumpsic Savings Bank’s holdings in Axon Enterprise were worth $5,987,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Groupama Asset Managment bought a new position in Axon Enterprise in the 3rd quarter valued at $200,000. Massachusetts Financial Services Co. MA purchased a new stake in shares of Axon Enterprise during the third quarter valued at $120,553,000. Westfield Capital Management Co. LP grew its holdings in shares of Axon Enterprise by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after purchasing an additional 127,769 shares during the last quarter. Assenagon Asset Management S.A. increased its stake in Axon Enterprise by 328.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock worth $86,354,000 after buying an additional 111,405 shares during the period. Finally, Champlain Investment Partners LLC lifted its holdings in Axon Enterprise by 13.9% during the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after buying an additional 83,265 shares in the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Northland Securities upped their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. The Goldman Sachs Group increased their price objective on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. TD Cowen began coverage on Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective on the stock. Craig Hallum cut Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 target price for the company. in a report on Thursday. Finally, Robert W. Baird raised their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Three analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Axon Enterprise presently has an average rating of “Moderate Buy” and a consensus price target of $561.31.

Insiders Place Their Bets

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jeffrey C. Kunins sold 2,304 shares of the business’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $654.79, for a total value of $1,508,636.16. Following the sale, the insider now owns 128,542 shares in the company, valued at $84,168,016.18. The trade was a 1.76 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 8,711 shares of company stock valued at $5,631,561. 6.10% of the stock is currently owned by insiders.

Axon Enterprise Stock Down 5.3 %

Shares of Axon Enterprise stock opened at $513.22 on Friday. Axon Enterprise, Inc. has a 52-week low of $265.32 and a 52-week high of $715.99. The firm’s 50 day moving average price is $619.94 and its 200-day moving average price is $517.11. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company has a market cap of $39.13 billion, a P/E ratio of 132.62, a PEG ratio of 5.43 and a beta of 1.05.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.